Status
INACTIVE
Global HQ
London, United Kingdom
Countries of investment
- United Kingdom
- USA
Investment stages
- Seed
- Series A
Industries
- Fintech
- AI
- Health Tech
- Blockchain
- Cryptocurrency
About
Summation Health Ventures (SHV.io) is a dynamic venture capital and private equity firm dedicated to fostering innovation in the healthcare technology landscape. Specializing in start-up and early to mid-stage investments, SHV.io targets information technology, technology-enabled devices, and service companies that demonstrate significant growth potential and transformative solutions. With a keen eye for groundbreaking ideas and experienced leadership, SHV.io is committed to empowering entrepreneurs and driving advancements that enhance patient care and operational efficiency in the healthcare sector. Through strategic partnerships and resource-driven support, the firm aims to cultivate a thriving ecosystem that propels its portfolio companies toward long-term success.
Summation Health Ventures (SHV.io) is a dynamic venture capital and private equity firm dedicated to fostering innovation in the healthcare technology landscape. Specializing in start-up and early to mid-stage investments, SHV.io targets information technology, technology-enabled devices, and service companies that demonstrate significant growth potential and transformative solutions. With a keen eye for groundbreaking ideas and experienced leadership, SHV.io is committed to empowering entrepreneurs and driving advancements that enhance patient care and operational efficiency in the healthcare sector. Through strategic partnerships and resource-driven support, the firm aims to cultivate a thriving ecosystem that propels its portfolio companies toward long-term success.
Investment Thesis
Invests in early stage technology startups with a focus on digital and datadriven innovations.
Manager's Experience
With extensive expertise in venture capital, the fund manager has successfully navigated over 30 investments across technology and healthcare sectors. Active in North America and Europe, their strategic style emphasizes a data-driven approach, capitalizing on early-stage opportunities. Noteworthy exits include several unicorns, showcasing a keen eye for high-potential startups. Their portfolio reflects a commitment to innovative solutions, leveraging operational experience to drive growth in emerging markets.